The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

July 2023

Starting Aug. 15, we’ll require prior authorization for some diabetes drugs

Beginning Aug. 15, 2023, health care providers for Blue Cross Blue Shield of Michigan and Blue Care Network commercial members will need to obtain prior authorization to show that the brand-name medications listed below are being used for Type 2 diabetes for us to pay for them. Medicare members are excluded from this change.

Brand-name medication

FDA-approved indication

 Plan payment requirement

Bydureon®
Byetta®
Mounjaro®
Ozempic®Rybelsus®
Trulicity®
Victoza®

Type 2 diabetes

Payment from Blue Cross or BCN will require one of the following:

  • Being used for the treatment of Type 2 diabetes
  • Trial of one generic or preferred medication for the treatment of Type 2 diabetes

Members should ask their prescribing doctor to contact us to request a prior authorization for the medications listed above. If the prescription isn’t authorized in advance, it may not be paid for.

We announced a similar change on Feb. 1, 2023, which didn’t apply to members who were already taking these medications. Effective Aug. 15, all members are required to have a prior authorization for these medications.

Providers can request prior authorization electronically. For information on how to submit the request:

  1. Go to ereferrals.bcbsm.com.
  2. Click on Blue Cross for commercial members or BCN for BCN members.
  3. Click on Pharmacy Benefit Drugs on the left.

For a complete list of drugs and associated requirements, go to bcbsm.com/druglists.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2022 American Medical Association. All rights reserved.